Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
119,358,581
-
Number of holders
-
174
-
Total 13F shares, excl. options
-
72,927,397
-
Shares change
-
+400,856
-
Total reported value, excl. options
-
$1,515,101,565
-
Value change
-
+$2,994,280
-
Put/Call ratio
-
38%
-
Number of buys
-
84
-
Number of sells
-
-94
-
Price
-
$20.78
Significant Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q4 2020
239 filings reported holding CYTK - CYTOKINETICS INC - COMMON STOCK as of Q4 2020.
CYTOKINETICS INC - COMMON STOCK (CYTK) has 174 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 72,927,397 shares
of 119,358,581 outstanding shares and own 61% of the company stock.
Largest 10 shareholders include BlackRock Inc. (11,611,079 shares), BVF INC/IL (4,878,035 shares), VANGUARD GROUP INC (4,821,989 shares), STATE STREET CORP (4,640,923 shares), Polar Capital Holdings Plc (3,271,884 shares), DRIEHAUS CAPITAL MANAGEMENT LLC (3,226,567 shares), WASATCH ADVISORS INC (2,555,740 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2,461,000 shares), FARALLON CAPITAL MANAGEMENT LLC (2,400,000 shares), and BOXER CAPITAL, LLC (2,100,000 shares).
This table shows the top 174 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.